Abstract: A blank for a package can include a substrate comprising a recyclable paper, the substrate having a first side and a second side opposite the first side. The blank can include one or more recyclable fluid resistant layers on the first side of the substrate configured to prevent water and/or oxygen from passing through to the substrate. The one or more recyclable fluid resistant layers can be configured to be an outside of the package. The blank can include a recyclable fluid permeable layer disposed on the second side and configured to allow a controlled amount of a fluid transmissibility and/or absorption by or through the fluid permeable layer.

Abstract: A recyclable corrugated board can include a first outer layer, a second outer layer, and a non-wicking medium attached to and disposed between the first outer layer and the second outer layer. The non-wicking medium is not impregnated and is not coated. The non-wicking medium can be corrugated paper, for example.

Abstract: A method for manufacturing a coated cellulosic substrate including delivering a blended starch composition to a metering size press and applying a coating of the blended starch composition from the metering size press onto a cellulosic substrate. The blended starch composition includes a lipophobic starch having a shear-thinning rheology and a food grade starch.

Abstract: A cellulosic structure includes a cellulosic substrate having a first major side and a second major side and a first barrier layer on the first major side of the cellulosic substrate. The first barrier layer has a plurality of perforations therethrough.

Abstract: A sliding shelf system includes a support structure including a plurality of posts, and a base mounted to the posts in a stationary manner. A slidable shelf is mounted to the base for movement between a stored position and an extended position. A wheel supports the shelf in the extended position. A notch is provided in the support structure for receipt of the wheel when the shelf is in the stored position. A latch includes a pivoting handle, a cable, and a slidable rod wherein pivoting of the handle moves the slidable rod. A rod with a hook engages an aperture in the pivoting handle of the latch of the slidable shelf. A socket on the slidable shelf receives a distal end of a rod, a proximal end of the rod defines a handle for grasping by the user.

Abstract: The present invention is directed to modulators of eosinophilic and neutrophilic function and the use of such modulators for treatment of eosinophil-associated and neutrophil-associated diseases.

Abstract: The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.

Abstract: The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.

Abstract: A water resistant structural board suitable for use in a wall system is disclosed. The structural board has water drainage channels on at least one of its surfaces to drain any water trapped behind the sealed wall system. The water drainage channels may be imparted into the structural board during or applied subsequent to a board production process, and the produced board is shipped to the construction site for a wall installation. When desired, the channeled surface of the structural board may be laminated, coated, or sprayed with a water resistant layer to further enhance the water resistant property of the board. A wall system including the disclosed structural board does not require a layer-by-layer installation of a component having water resistant property and a component having water drainage channel structure at a work site; therefore, labor cost and installation time may be reduced significantly.

Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.

Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.

Abstract: The invention features a transgenic mouse that expresses human formyl peptide receptor and methods for producing this mouse. The invention also features methods for the measurement of an inflammatory response, particularly that associated with cystic fibrosis. The methods of the invention also feature methods for determining whether a compound inhibits or prevents the recruitment of neutrophils.

Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.

Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.

Abstract: The invention is directed to an improved infant formula containing a lipid blend that softens the firmer stools associated with typical infant formula. A specific formula in accordance with the invention comprises carbohydrates, proteins, vitamins and minerals and a lipid mixture of high oleic safflower oil, soy oil and coconut oil at specific levels and ratios. The invention also discloses novel mixtures of fatty acids that provides infant stool patterns more closely resembling the breast-fed infant.

Abstract: The invention is directed to an improved infant formula containing a lipid blend that softens the firmer stools associated with typical infant formula. A specific formula in accordance with the invention comprises carbohydrates, proteins, vitamins and minerals and a lipid mixture of high oleic safflower oil, soy oil and coconut oil at specific levels and ratios. The invention also discloses novel mixtures of fatty acids that provides infant stool patterns more closely resembling the breast-fed infant.

Abstract: The invention provides methods and compositions for screening and identifying peptide aptamers that can modulate a cell phenotype and further, can be used for the treatment of a disease involving a misregulated cell phenotype, such as, for example, a cancer.

Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.

Abstract: The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.

Abstract: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2ad/db protein, either directly or by gene transfer techniques, to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.